Profil
Sondra S.
Newman is currently the Global Head-Investor Relations at Repligen Corp.
Prior to this, she worked as the Director-Investor Relations at NitroMed, Inc.
Postes actifs de Sondra S. Newman
| Sociétés | Poste | Début |
|---|---|---|
| REPLIGEN CORPORATION | Investor Relations Contact | - |
Anciens postes connus de Sondra S. Newman
| Sociétés | Poste | Fin |
|---|---|---|
NitroMed, Inc.
 NitroMed, Inc. Pharmaceuticals: MajorHealth Technology NitroMed, Inc. develops and supplies pharmaceuticals. It offers BiDil, an orally administered medicine for the treatment of heart failure. The firm also develops products for cardiovascular and metabolic diseases. The company was founded in 1987 and is headquartered in Atlanta, GA. | Public Communications Contact | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| REPLIGEN CORPORATION | Health Technology |
| Entreprise privées | 1 |
|---|---|
NitroMed, Inc.
NitroMed, Inc. Pharmaceuticals: MajorHealth Technology NitroMed, Inc. develops and supplies pharmaceuticals. It offers BiDil, an orally administered medicine for the treatment of heart failure. The firm also develops products for cardiovascular and metabolic diseases. The company was founded in 1987 and is headquartered in Atlanta, GA. | Health Technology |
